NCT05216016

Brief Summary

MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. (Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 23, 2021

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 18, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 31, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

October 30, 2025

Status Verified

October 1, 2025

Enrollment Period

4.4 years

First QC Date

January 18, 2022

Last Update Submit

October 29, 2025

Conditions

Injuries Related WorkIllness Related WorkDisability

Keywords

RETAINMinnesota RETAINMN RETAINIllness RecoveryInjury RecoveryOut of work helpWork placement assistanceJob helpWork HelpHelp keeping my jobStay at workReturn to work

Outcome Measures

Primary Outcomes (3)

  • Workers to maintain employment

    Total number of workers employed at the time of program completion and who have maintained employment 12 months after enrollment.

    12 months

  • Reduction on work disability at 1 years

    Total number of enrollees that applied for SSDI or SSI during any of the 1 year after enrollment.

    1 year

  • Reduction in long term work disability

    Total number of enrollees that applied for SSDI or SSI during any of the 5 year after enrollment.

    5 years

Study Arms (3)

Control Group

NO INTERVENTION

Individuals will receive a handout with additional job related services; e.g. Job Accommodation Network.

Intervention Group

EXPERIMENTAL

Individuals will be assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager. Intervention group participants will be referred for additional career and workforce development resources when needed.

Other: RETAIN Program

Sub Study Group

EXPERIMENTAL

Individuals will be assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager. Intervention group participants will be referred for additional career and workforce development resources when needed.

Other: RETAIN Program

Interventions

RETAIN ProgramOTHER

Facilitates early intervention strategies to support workers in staying-at or returning-to-work (SAW/RTW) after injury or illness and preventing unnecessary disability. This is done by incorporating a Return-to-Work Case Manager as a member of the healthcare clinical team who acts as a liaison for the patient and assists in coordination of referrals between healthcare and Workforce Development services. Return-to-Work Case Managers will interact with treating providers of Minnesota RETAIN intervention group participants to ensure functionally based work restrictions are documented and shared with the patient's employer.

Intervention GroupSub Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18-years-old
  • MN Resident
  • Works in MN
  • Employed at the time of enrollment
  • Within 6 months of last day of work
  • Meets one of the following:
  • Provider work restrictions of unable to work for at least 4 weeks
  • Per healthcare team anticipated to be unable to work for at least 4 weeks
  • Employer's inability to accommodate current work restrictions
  • Meets one of the following:
  • Diagnosis of a work related or personal injury or illness that impacts employment
  • Invasive procedure (e.g., surgery) anticipated within the next 4-weeks that impacts employment
  • Documentation of work restrictions (i.e., written note/form documentation in electronic medical record prior to enrollment)

You may not qualify if:

  • Legal representation/litigation at the time of enrollment related to a workers' compensation medical condition
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e., Mayo Clinic employees)
  • Workers' compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)
  • Pending application OR Receiving Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI)
  • Self-Employed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Rochester

Rochester, Minnesota, 55905, United States

Location

Study Officials

  • Laura Breeher, MD, MPH

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

  • Clayton Cowl, MD,MS

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 18, 2022

First Posted

January 31, 2022

Study Start

December 23, 2021

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

October 30, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations

US(1)